- Three Middle Eastern aluminum plants collectively cut production by approximately 2.63 million tons
- Strategy did not purchase any bitcoin in the past week
- KBRO Leverages Harmonic's Fiber-on-Demand Solution for Network Upgrades
- Sagtec Global (NASDAQ: SAGT) to Launch Sovereign AI Data Center Powered by NVIDIA GPU Architecture; Infrastructure Pivot to Support Millions of Daily F&B Retail Ordering, Retail and Fintech Transactions
- VisionWave Provides Corporate Update on Planned Expansion of Multi-Domain Intelligence Platform Across Defense, Energy, and Autonomous Systems
- Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair (omalizumab)
- Esperion Showcases New Data from CLEAR Outcomes Highlighting Value of NEXLETOL (bempedoic acid) at the American College of Cardiology's Annual Scientific Session 2026
- Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development
- PMI U.S. BRINGS TECHNOVATION TO WASHINGTON D.C.
- Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
- BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
- AXIL Brands to Introduce GSX 3.0 and XCOR Pro Hearing Protection Products Nationwide at Sportsman's Warehouse
- Terra Innovatum Enhances Leadership for Commercial Scale-Up with Appointment of Former AREVA CEO and CFO Kathy Williams
- Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology
- CCC Intelligent Solutions Adds All Clear to Diagnostics Network
- Aprea Therapeutics Announces Oversubscribed $30 Million Private Placement
- BRC Group Holdings, Inc. Launches BRC Specialty Finance
- Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- electroCore Expands Intellectual Property Portfolio
- Journal of Urology Publishes ENVISION Trial Results Showing 72.2% 24-Month Duration of Response with ZUSDURI
- Pacira BioSciences to Present Real-World Data on EXPAREL Showing Reduced Cost of Care at Orthopaedic Research Society 2026 Annual Meeting
- Willis Lease Finance Corporation Amends Revolving Credit Facility
- Aprea Therapeutics Highlights Positive Emerging Clinical Activity for WEE1 Inhibitor, APR-1051, with a Confirmed Partial Response in the Ongoing Phase 1 ACESOT-1051 Trial
- PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
- JE Cleantech Secures approximately USD$12 million
- Nasdaq Concludes Public Consultation on Nasdaq-100 Index Methodology
- Vor Bio Doses First Patient in Global Phase 3 UPSTREAM SjD Registrational Trial of Telitacicept in Primary Sjogren's Disease
- Lianhe Sowell International Group Ltd. Announces $1.8 Million Contract to Develop AI Steam Car-Wash Robot Promising Significant Water Savings
- Japanese Yen Collapse Triggers Worldwide Market Turmoil Amid Sliding South Korean Stocks
- Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial Results
- Institution: Amid the backdrop of the Middle East war, investors should focus on long-term prospects
- Yen hits 160 again—will this time scare off the shorts?
- Koppers to Ring NYSE Closing Bell to Celebrate 20th Anniversary of Listing; Management Hosting Meetings with the Financial Community in New York
- CHIPOTLE LAUNCHES BURRITO VAULT: DOUBLE PROTEIN EDITION WITH OVER $2 MILLION IN CHIPOTLE PRIZES FOR NATIONAL BURRITO DAY
- A trader held ANIME for one year and made a 211x profit, turning 1.1 SOL into 232.2 SOL.
- Futures Hotspot Tracking
- The Multicoin co-founder invested $10 million using DeFi leverage
- Golden Ten Data Futures Heat Map
- According to the latest official filing submitted to the U.S. Securities and Exchange Commission (SEC), Vine Hill Capital Investment Corp (VCIC) has decided to initiate the delisting procedure from the Nasdaq exchange.
- According to the latest filing with the U.S. Securities and Exchange Commission, ATMOS Energy Corporation has officially extended the maturity date of its five-year credit agreement to March 28, 2031. This adjustment will take effect on March 27, 2026.
- Raymond James announced that it has downgraded Boston Scientific's investment rating from "Strong Buy" to "Outperform," and lowered its target price from $97 to $88.
- JPMorgan recently released a research report, providing its initial coverage on hard disk manufacturer Seagate Technology and assigning an "overweight" rating.
- Virtuix Signs Cooperative Research and Development Agreement with U.S. Navy
- Quantum BioPharma Signs Binding Letter Of Intent With Allucent To Conduct Phase 2 Clinical Trial In Multiple Sclerosis
- Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
- Nvidia vs. XRP: Which $1,000 Investment Wins by the End of 2026?
- Obol Labs co-founder Oisin Kyne has taken over as CEO and has laid off approximately 30% of staff.
- Capital Economics: The energy shock has not yet significantly weighed on Eurozone business activity
- Brent: War premium drives gains – Danske Bank
- Bitcoin March 30 daily chart alert - Bears working on price downtrend
- Gold price outlook for March 30 – important intraday entry points for active traders
- Cardano Targets Historic Support Retest Amid Rejection from 1D Mitigation Block
- Bitcoin, ether bounce is running low on fuel
- Data Shows XRP Has Officially Slipped into a Full-Blown Bear Market
- World’s Largest Banks Are Currently Using XRP In “Test Mode.”
- Bitcoin Breaks Macro Models Again as $72.5K Resistance Holds
- BTQ Technologies to Host Live Webinar on 2025 Financial Results and General Corporate Update
- BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
- BeyondSpring Announces Plinabulin and ADC Combination Poster Presentation at AACR Annual Meeting 2026
- InflaRx Highlights Clinical Activity of Vilobelimab in Pyoderma Gangrenosum in Late-Breaker Oral Presentation at 2026 American Academy of Dermatology Annual Meeting
- BridgeBio Submits NDA to FDA for BBP-418 for Individuals Living with LGMD2I/R9
- Bicara Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
- Medicus Pharma Reports KOL Validation of SkinJect Phase 2 Data of 80% Overall Response Rate
- Bitfarms to Participate in Jefferies Fireside Chat
- Palvella Therapeutics Announces Scientific Publication in Journal of Vascular Anomalies Highlighting the Infiltrative Growth and Therapeutic Challenges of Microcystic Lymphatic Malformations
- Anavex Life Sciences Provides Comprehensive Regulatory Update
- Liquidity for blockchain yield products set to improve after $50 million investment in Midas
- Customer Success Is Becoming the Strategy Desk in Crypto Payments
- Solana price confirms bearish flag pattern as ETFs break 6-week inflow streak, will it crash?
- Hyperliquid, SUI drive $643M in token unlocks this week
- Alterity Therapeutics Receives Positive FDA Feedback Following Type C Meeting on ATH434 Phase 3 Program
- Russell 3000 Index Stock Short Interest Hits 15-Year High
- XRP EMA Crossover Shows When XRP Could Bottom This Cycle
- Bitcoin Price Prediction: Oil at $100 Puts BTC Price Under a Real ‘Trial by Fire’
- Are Tokenized Stocks Crypto’s Next $5T Opportunity? Nasdaq, SEC, and Congress All Move at Once
- Major U.S. Economic Event To Watch This Week
- Ripple CEO Traces Crypto From Rat Poison to Pet Rock, Says CLARITY Act Will Decide if Wall Street Goes All In
- Monthly Close Alert: TAO, FET, CHZ, & DEXE Set for Potential Breakouts
- SIREN Price Rebounds Strongly: Is This the Start of a New Uptrend?
- Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
- Crypto Expert Discusses Possibility for Bullish Rally Overnight, Saying It’s Darkest Before the Dawn
- Ontology Price Prediction: ONT Surges 19% as ONT Tests Key Breakout Above $0.074
- Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
- Sasol Financing USA LLC Announces the Commencement of Cash Tender Offers for Outstanding Debt Securities and New Senior Notes Offering
- Connect Biopharma Announces $20.2 Million Private Placement Financing
- PMGC Holdings Inc. [NASDAQ: ELAB] Reports 2025 Annual Results and Files Form 10-K, Company Expands Asset Base to $13.8M, a 43% Increase from 2024
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
- Midas Completes $50 Million Series A Funding Round, Led by RRE Ventures and Creandum
- Goldman Sachs: Market Pessimism Nears Limit, Stock Market May Surge if War Situation Eases
- Connect Biopharma Announces Positive Topline Data from its Phase 1 Study of Intravenous (IV) Rademikibart in Patients with Asthma or COPD
- USA Rare Earth Reports Fourth Quarter and Full-Year 2025 Financial Results
- Hope Therapeutics, an NRx Pharmaceuticals Subsidiary (Nasdaq:NRXP), Announces Strategic Partnership with Emobot to Integrate its AI-Powered "Depression Thermometer" Across its Interventional Psychiatry Network
- Aura Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
- Rademikibart Demonstrates Best-in-Class Potential in Phase 3 Atopic Dermatitis Study
- Smart Share Global Limited Granted Exception by Nasdaq Staff Related to Filing of Its Interim Report
- PDS Biotech Reports Full Year 2025 Financial Results and Provides Update on PDS0101 Phase 3 Program and PDS01ADC Clinical Advancement
- Boardwalk Pipelines Enters Agreement to Acquire Spire Marketing
- Fermi America Reports Fiscal Year 2025 Earnings, Marking Operational Milestones on the Path to 17 GW of Private Power
- Aquestive Therapeutics Announces Completion of Type A Meeting with FDA for Anaphylm (dibutepinephrine) Sublingual Film
- Oatly to Report First Quarter 2026 Financial Results on April 29, 2026